Form 4: Biogen Executive Gregory Ginger Reports Stock Transactions
SEC Form 4 Filing
EVP of Human Resources at Biogen, Gregory Ginger, reports acquisition and disposal of common stock and restricted stock units.
Summary
- Gregory Ginger, EVP of Human Resources at Biogen, filed a Form 4 detailing changes in beneficial ownership.
- On February 7, 2025, Ginger acquired 1,635 shares of common stock and disposed of 480 shares at a price of $141.35.
- Additionally, Ginger acquired 1,801 shares of common stock and disposed of 560 shares at a price of $141.35 on the same day.
- Following these transactions, Ginger beneficially owns 16,073.1006 shares of common stock.
- Ginger also acquired 11,240 restricted stock units on February 6, 2025, which vest in three equal yearly installments beginning on February 6, 2026.
- He also owns 3,604 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies to ensure transparency and compliance with securities regulations.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock transactions.
- It ensures compliance with SEC regulations, maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of acquisition of 93.3846 shares under the Biogen Inc. employee stock purchase plan. |
| 02/06/2025 | Date of grant of 11,240 restricted stock units. |
| 02/06/2026 | First vesting date for the 11,240 restricted stock units. |
| 02/07/2025 | Date of common stock and restricted stock unit transactions. |
| 02/08/2023 | Grant date of restricted stock units that vest in three equal annual installments commencing one year after this date. |
| 02/07/2024 | Grant date of restricted stock units that vest in three equal annual installments commencing one year after this date. |
| 02/10/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Biogen, BIIB, Gregory Ginger, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.